Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Masri

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Transplantation Proceedings|October 1, 1992
Cyclosporine blood level monitoring by three specific methods; RIA H3, RIA I125, and fluorescence polarization: comparison of accuracy, cost, reproducibility and percent recoveryM A Masri
Transplantation Proceedings|February 1, 1995
Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin graftsM A Masri
Transplantation Proceedings|October 1, 1992
Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of bothM A Masri
Transplantation Proceedings|November 13, 2003
The role of generics in transplantationM A Masri, T Andrysek, V Matha
Kidney International|May 1, 1985
Role of fibrinogen in the glomerular permeability of the perfused, isolated dog kidneyM A Masri, N D Boyd, H Mandin
Transplantation Proceedings|February 1, 1989
Immunopathological changes in the spleen of BALB/c mice treated with either cyclosporine A or cyclosporine GM A Masri, M Naiem, A S Daar
Thrombosis and Haemostasis|April 28, 1983
Isolation o human fibrinogen of high purity and in high yield using polyethylene glycol 1000M A Masri, S A Masri, N D Boyd
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 24, 2007
Calcineurin inhibitor-free protocols: risks and benefitsA G Barbari, A G Stephan, M A Masri
Transplantation Proceedings|November 20, 1997
Immunosuppressive therapy in renal transplant patients according to patient immunological statusM A Masri, G Kamel, A Barbari, et al.
Transplantation Proceedings|March 12, 2004
The role of generics in transplantation: TM-MMF versus Cellcept in healthy volunteersM A Masri, T Andrysek, S Rizk, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Transplantation Proceedings|October 1, 1992
Cyclosporine blood level monitoring by three specific methods; RIA H3, RIA I125, and fluorescence polarization: comparison of accuracy, cost, reproducibility and percent recoveryM A Masri
Transplantation Proceedings|February 1, 1995
Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin graftsM A Masri
Transplantation Proceedings|October 1, 1992
Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of bothM A Masri
Transplantation Proceedings|November 13, 2003
The role of generics in transplantationM A Masri, T Andrysek, V Matha
Kidney International|May 1, 1985
Role of fibrinogen in the glomerular permeability of the perfused, isolated dog kidneyM A Masri, N D Boyd, H Mandin
Transplantation Proceedings|February 1, 1989
Immunopathological changes in the spleen of BALB/c mice treated with either cyclosporine A or cyclosporine GM A Masri, M Naiem, A S Daar
Thrombosis and Haemostasis|April 28, 1983
Isolation o human fibrinogen of high purity and in high yield using polyethylene glycol 1000M A Masri, S A Masri, N D Boyd
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 24, 2007
Calcineurin inhibitor-free protocols: risks and benefitsA G Barbari, A G Stephan, M A Masri
Transplantation Proceedings|November 20, 1997
Immunosuppressive therapy in renal transplant patients according to patient immunological statusM A Masri, G Kamel, A Barbari, et al.
Transplantation Proceedings|March 12, 2004
The role of generics in transplantation: TM-MMF versus Cellcept in healthy volunteersM A Masri, T Andrysek, S Rizk, et al.
Pageof 6